Antibody Pair for Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP)

MAC-2-BP; LGALS3-BP; Galectin-3-Binding Protein; L3 Antigen; Mac-2-Binding Protein; Tumor-associated antigen 90K; Serum Protein 90K; Basement membrane autoantigen p105

  • Product No.PSB766Hu01
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • Reagent Contents
    Recombinant Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) 50ug Standard
    Monoclonal Antibody to Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) 500ug Capture Ab
    Biotin-Linked Monoclonal Antibody to Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) 200ug Detection Ab
  • ApplicationsELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
  • Downloadn/a
  • UOM 96T*596T*10 96T*20 96T*50 96T*100
  • FOB US$ 1078  US$ 1796  US$ 3233  US$ 6286  US$ 10776 
    For more details, please contact local distributors!

MATCHING TESTS

USAGE

The concentration of protein/peptide and antibodies used in different immunoassays need to be determined by users according to their experiments.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Andrology Comparative proteomic analysis coupled with conventional protein assay as a strategy to identify predictors of successful testicular sperm extraction in patients with non-obstructive azoospermia PubMed: 23427166
Liver International Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 4-D DIGE Pubmed: 23944848
Acta Anaesthesiologica Scandinavica Early prognostic factors in septic shock cancer patients: a prospective study with a proteomic approach Pubmed:29315472